Cidara Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Cidara Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Cidara Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $3.32M, a 22.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.32M -$986K -22.9% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.6M +$2.76M +331% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $3.79M +$2.69M +245% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 $4.05M +$2.7M +199% Sep 30, 2023 10-K 2024-04-22
Q2 2023 $4.31M +$2.71M +169% Jun 30, 2023 10-K 2024-04-22
Q1 2023 $836K -$1.01M -54.7% Mar 31, 2023 10-K 2024-04-22
Q4 2022 $1.1M -$1.19M -51.9% Dec 31, 2022 10-K 2024-04-22
Q3 2022 $1.35M -$1.19M -46.7% Sep 30, 2022 10-K 2024-04-22
Q2 2022 $1.6M +$1.16M +259% Jun 30, 2022 10-K 2024-04-22
Q1 2022 $1.85M +$1.18M +178% Mar 31, 2022 10-K 2024-04-22
Q4 2021 $2.29M +$1.42M +163% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $2.54M +$1.48M +139% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $446K -$811K -64.5% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $663K -$784K -54.2% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $868K -$764K -46.8% Dec 31, 2020 10-K 2022-03-07
Q3 2020 $1.06M -$747K -41.3% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $1.26M -$726K -36.6% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $1.45M -$684K -32.1% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $1.63M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.81M Sep 30, 2019 10-Q 2019-11-08
Q2 2019 $1.98M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $2.13M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.